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The phagocyte NADPH oxidase mediates oxidative
microbial killing in granulocytes and macrophages.
However, because the reactive oxygen species
produced by the NADPH oxidase can also be toxic
to the host, it is essential to control its activity. Little
is known about the endogenous mechanism(s) that
limits NADPH oxidase activity. Here, we demonstrate
that the myeloid-inhibitory receptor SIRPa acts
as a negative regulator of the phagocyte NADPH
oxidase. Phagocytes isolated from SIRPa mutant
mice were shown to have an enhanced respiratory
burst. Furthermore, overexpression of SIRPa in
human myeloid cells prevented respiratory burst
activation. The inhibitory effect required interactions
between SIRPa and its natural ligand, CD47, as
well as signaling through the SIRPa cytoplasmic
immunoreceptor tyrosine-based inhibitory motifs.
Suppression of the respiratory burst by SIRPa was
caused by a selective repression of gp91phox expres-
sion, the catalytic component of the phagocyte
NADPH oxidase complex. Thus, SIRPa can limit
gp91phox expression during myeloid development,
thereby controlling the magnitude of the respiratory
burst in phagocytes.
INTRODUCTION
One of the most important antimicrobial activities of phagocytes
is the abrupt formation of reactive oxygen species (ROS),
a process known as the respiratory burst. This is mediated by
the phagocyte NADPH oxidase complex, and its importance is
best illustrated by patients with chronic granulomatous disease
(CGD) and dysfunctional NADPH oxidase, and as a result are
hypersusceptible to a variety of bacterial and fungal infections
(Roos et al., 2003; Bedard and Krause, 2007). The phagocyte
NADPH oxidase is a multisubunit enzyme complex composed748 Cell Reports 2, 748–755, October 25, 2012 ª2012 The Authorsof (1) the membrane proteins gp91phox (NOX2, the catalytic
component of the oxidase) and p22phox; (2) the cytosolic proteins
p40phox, p47phox, and p67phox; and (3) the small GTPase Rac.
Activation of the oxidase involves translocation of the cytosolic
subunits p40phox, p47phox, p67phox, and Rac to the plasma
membrane and assembly of the oxidase complex. Once assem-
bled, the NADPH oxidase generates superoxide (O2
) formation
by transferring electrons from NADPH in the cytosol over the
plasma membrane to molecular oxygen. Superoxide produced
by the oxidase forms the basic compound from which other
ROS, such as hydrogen peroxide (H2O2) and hypochlorous
acid (HOCl), are formed. High concentrations of ROS are directly
toxic to microbes, and may also be indirectly toxic due to the
liberation of hydrolytic proteases (Reeves et al., 2002).
The mechanisms of NADPH oxidase activation have been
relatively well characterized, but essentially nothing is known
about whether and how the magnitude of the respiratory burst
is controlled. The latter is important because ROS not only
play a critical role in host defense but can also be toxic to the
host. The tight control over NADPH oxidase activity is illustrated
in part by the observation that there is only very little interindi-
vidual variation in the respiratory burst (Zhao et al., personal
communication). The magnitude of the respiratory burst is likely
to be primarily determined by the protein expression levels of the
various NADPH oxidase components, which are expressed in
a developmentally regulated fashion in phagocytes. Although
the developmental pathways and transcription factors that
trigger the expression of the different NADPH oxidase compo-
nents during myeloid development have been established (Lind-
sey et al., 2007; Zhu et al., 2008; Kautz et al., 2001), the putative
regulatory mechanisms that counterbalance these factors and
prevent excessive, potentially harmful expression of the various
NADPH oxidase components within phagocytes have remained
unknown.
SIRPa is an inhibitory immunoreceptor that is predominantly
expressed on myeloid and neuronal cells (Fujioka et al., 1996;
Adams et al., 1998). The cytoplasmic region of SIRPa contains
four immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
that upon ligand binding become phosphorylated and mediate
the recruitment and activation of the SH2-domain-containing
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Figure 1. Phagocyte NADPH Oxidase
Activity Is Enhanced in Macrophages and
Granulocytes from SIRPa Mutant Mice
(A) Flow-cytometric double labeling of bone-
marrow cells for CD31 and Ly-6C, identifying the
major subpopulations of hematopoietic cells.
(B and C) Sorted populations of (B) monocytes,
granulocytes, lymphocytes, and immature mye-
loid cells, or (C) cultured bone-marrow-derived
macrophages from WT (white bars) or SIRPa
mutant (black bars) C57BL/6 mice were evaluated
for PMA-induced NADPH oxidase activity.
Data are the means ± SD of five animals, with
each measurement performed in triplicate. Sig-
nificance was determined by Student’s t test.
See also Figure S1.tyrosine phosphatases (PTPase) SHP-1 and SHP-2. SHP-1 and
SHP-2 can in turn dephosphorylate specific protein substrates
and thereby mediate various biological functions, generally in
a negative fashion. The N-terminal V-like Ig domain mediates
recognition of the broadly expressed transmembrane glycopro-
tein CD47 (Jiang et al., 1999; Seiffert et al., 1999; Vernon-Wilson
et al., 2000; Liu et al., 2007; Lee et al., 2007; Hatherley et al.,
2008). SIRPa has been implicated in the regulation of a number
of functions in myeloid cells (van Beek et al., 2005; Barclay and
Brown, 2006). One of the best-documented functions of SIRPa
is its inhibitory role in the phagocytosis of host cells by macro-
phages. In particular, the ligation of SIRPa on macrophages by
the ‘‘don’t eat me’’ signal CD47 expressed on host cells, such
as erythrocytes and platelets, generates an inhibitory signal
that negatively regulates phagocytosis (Oldenborg et al., 2000;
Yamao et al., 2002). This suggests that CD47 acts as amolecular
signature of self that limits immune-mediated damage against
normal and healthy host cells during infection and inflammation
by interacting with the self sensor SIRPa on phagocytes and
other myeloid cells. However, until now, a direct involvement
of CD47-SIRPa interactions in the regulation of inflammatory
mediators and antimicrobial functions has not been reported.
Here we demonstrate that SIRPa acts as a critical negative
regulator of the respiratory burst. Inhibition of the phagocyteCell Reports 2, 748–755,NADPH oxidase by SIRPa involves
interactions between SIRPa and the self
molecule CD47, as well as signaling
through the SIRPa ITIMs, which result
in a selective suppression of gp91phox
expression. This mechanism may help
prevent collateral oxidative damage to
the host during infection and other in-
flammatory conditions.
RESULTS AND DISCUSSION
Enhanced NADPH Oxidase Activity
in SIRPaMutant Phagocytes
To investigate whether SIRPa signaling
regulates the phagocyte NADPH oxidase,
we performed studies with cells fromSIRPa mutant mice. These mice express a SIRPa molecule
lacking the cytoplasmic tail and signaling capacity (Yamao
et al., 2002). We sorted distinct bone-marrow cell populations
of SIRPa mutant and control mice, including granulocytes,
monocytes, immature myeloid cells, and lymphoid cells, by
fluorescence-activated cell sorting (FACS) using CD31 and
Ly-6C as markers (Figure 1A) as described previously (Nikolic
et al., 2003), and analyzed their phorbol myristate acetate
(PMA)-induced respiratory burst. As reported previously (van
Beek et al., 2009), there were no detectable differences in
bone-marrow composition between the mutant and control
mice, essentially excluding a prominent nonredundant role of
SIRPa signaling in myeloid differentiation. We observed a sig-
nificantly (50%–75%) enhanced respiratory burst activity in
granulocytes and monocytes from SIRPa mutant mice in com-
parison with cells from wild-type (WT) mice (Figure 1B). A similar
difference was seen in bone-marrow-derived macrophages
(Figure 1C). The respiratory burst in immature myeloid cells
(Figure 1B) appeared unaffected. A comparison of WT and
SIRPa mutant mice showed that the production of other inflam-
matory mediators, including nitric oxide (NO), tumor necrosis
factor a (TNFa), interleukin 1b (IL1b), IL6, and IL10, by bone-
marrow-derived macrophages in response to lipopolysaccha-
ride (LPS) was not significantly affected (Figure S1). Collectively,October 25, 2012 ª2012 The Authors 749
these data indicate a selective inhibitory role for SIRPa signaling
in the regulation of the respiratory burst.
The lack of difference between WT and SIRPamutant phago-
cytes appears to be in contrast to previous reports (Kong et al.,
2007; Dong et al., 2008), in which knockdown of SIRPa in
macrophages was shown to enhance cytokine production in
response to TLR ligands. A possible explanation for this
apparent discrepancy is that inhibition of cytokine production
can only be caused by a complete absence of SIRPa, and not
by selective deletion of its cytoplasmic tail. A more trivial ex-
planation could relate to differences in the method used for
interference. We used macrophages from gene-targeted
knockout mice, whereas the other studies used small hairpin
RNA (shRNA)- and small interfering RNA (siRNA)-mediated
knockdown, which may have triggered macrophage danger
pathways that contributed to the response (Stacey et al.,
2000). Our current findings essentially exclude a regulatory
role for SIRPa signaling in TLR-induced cytokine production,
and support the idea that SIRPa signaling regulates selected
inflammatory mediators, such as ROS.
SIRPa Overexpression Inhibits the NADPH Oxidase
in Human Phagocytic Cells
To investigate the mechanism by which SIRPa regulates the
phagocyte respiratory burst, we tested the effect of overexpres-
sion of SIRPa in human myeloid PLB-985 cells. PLB-985 cells
are suitable for studying NADPH oxidase activity (Zhen et al.,
1993), and were found to express relatively low levels of endog-
enous SIRPa as shown by western blotting (Figure S2A) and
flow cytometry (Figure S4A). A chimeric rat-human SIRPa pro-
tein was expressed in PLB-985 cells because it allows for
selective monitoring and manipulation by the agonistic mono-
clonal antibody (mAb) ED9 specifically directed against the rat
SIRPa extracellular domain (Adams et al., 1998; Alblas et al.,
2005). PLB-985 cells, or mutants with a targeted mutation of
the gp91phox gene (PLB-985 X-CGD; Zhen et al., 1993), were ret-
rovirally transduced with full-length chimeric rat-human SIRPa
protein (SIRPa-WT) or a SIRPa deletion mutant (SIRPa-D87)
that is unable to signal because it lacks the cytoplasmic tail. A
flow-cytometric analysis showed that the levels of SIRPa
expression were comparable for the different cell lines generated
(Figure 2A) and similar to those generally seen in rat myeloid
cell lines or primary rat myeloid cells, such as macrophages
or granulocytes (Adams et al., 1998; not shown). Western
blotting with an antibody against the cytoplasmic tail of SIRPa
identified both endogenous and chimeric SIRPa proteins, and
confirmed that SIRPa-D87 cells express a truncated SIRPa
(Figure S2A).
We studied the respiratory burst in the different PLB-985 cells
after in vitro granulocytic or monocytic differentiation using
dimethylformamide (DMF) or vitamin D3 (VitD3), respectively.
PMA-induced NADPH oxidase activity was normal in control
cells but was abolished in cells expressing WT SIRPa (Figures
2B and 2C). This effect occurred after either granulocytic or
monocytic differentiation. Clearly, the inhibitory effect was not
observed in the SIRPa-D87 mutant, suggesting that SIRPa
signaling was required. In fact, the SIRPa-D87 cells generated
a considerably higher response than the empty vector cells,750 Cell Reports 2, 748–755, October 25, 2012 ª2012 The Authorssuggesting that the mutant SIRPa protein acted as a domi-
nant-negative protein by competing with, e.g., endogenous
SIRPa for CD47 binding (see below). Of importance, all
responseswere entirely attributable to the gp91phox (NOX2)-con-
taining phagocyte NADPH oxidase, because they were
completely absent in the PLB-985 X-CGD cells, which have a
targetedmutation of the gp91phox-encodingCYBB gene. Among
several other tested stimuli of NADPH oxidase activation (i.e.,
serum-treated zymosan [STZ], formyl-methionyl-leucyl-phenyl-
alanine [fMLP], and human IgG complexes), only STZ generated
a measurable response in the PLB-985 cells, and again this was
completely abrogated by SIRPa-WT expression (Figure S2B).
This is consistent with a generalized effect of SIRPa on the
NADPH oxidase.
SIRPa Selectively Represses gp91phox Expression
during Myeloid Differentiation
Activation of the multisubunit NADPH oxidase complex
requires assembly of its individual components, which are ex-
pressed during myeloid differentiation (Roos et al., 2003). To
establish the basis for SIRPa-dependent regulation of the
respiratory burst, we investigated the expression levels of the
different components of the NADPH oxidase complex upon
myeloid differentiation. Expression of the membrane compo-
nent gp91phox, which forms the enzymatic core of the phago-
cyte NADPH oxidase, was evaluated in undifferentiated or
granulocytic or monocytic differentiated PLB-985 cells by
western blotting. The differentiation-induced rise in gp91phox
expression was completely absent in cells that express the
full-length SIRPa protein (SIRPa-WT; Figure 2D). The same
was observed when surface levels of gp91phox were analyzed
by flow cytometry with 7D5 mAb (Figure S3A). Also, the
enhanced respiratory burst activity in cells that express the
truncated receptor (SIRPa-D87) was associated with a higher
gp91phox expression. Of importance, the levels of two other
NADPH oxidase components, p67phox and p47phox, remained
unaffected by overexpression of full-length or truncated SIRPa
(Figure 2D), suggesting that SIRPa was selectively regulating
gp91phox expression. However, the similar levels of upregula-
tion of p47 and p67 observed in the empty vector, SIRPa-WT,
and SIRPa-D87 cells also indicated that differentiation was
unaffected by the introduction of SIRPa-WT or SIRPa-D87,
suggesting that SIRPa was not regulating differentiation in
general. Furthermore, SIRPa did not affect the upregulation
of other myeloid differentiation markers, such as CD11b and
CD14, during granulocytic or monocytic differentiation (not
shown). The upregulation of endogenous SIRPa on PLB-985
cells coincided with that of gp91phox at days 1–3 of neutrophilic
differentiation (Figure S3B).
To demonstrate that gp91phox was indeed the only relevant
factor downregulated by SIRPa, gp91phox was reconstituted by
retroviral expression into SIRPa-WT cells (Figure 2E), and this
resulted in a full restoration of the respiratory burst (Figure 2F).
A similar restoration was observed when such reconstitution
was performed in PLB-985 X-CGD cells. This shows that
SIRPa suppresses phagocyte NADPH oxidase activity by a
selective repression of gp91phox protein expression during
myeloid differentiation.
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Figure 2. SIRPa Overexpression in PLB-985
Cells Inhibits the Respiratory Burst by Re-
pressing gp91phox Expression
PLB-985 and gp91phox PLB-985 X-CGD cells were
stably transduced with empty vector, chimeric
rat-human SIRPa (SIRPa-WT), or an N-terminal
truncated SIRPa protein lacking 87 amino acids of
the cytoplasmic tail of SIRPa (SIRPa-D87).
(A) SIRPa surface expression was evaluated by
flow cytometry with Alexa 633-conjugated ED9
directed against rat SIRPa antibody (solid histo-
grams). Unstained cells are indicated as control
(open histogram).
(B andC) PMA-inducedNADPH-oxidase activity in
the indicated PLB-985 (white bars) and PLB-985
X-CGD (black bars) cell lines after 5–6 days of
either granulocytic (B) or monocytic (C) differenti-
ation induced with DMF or VitD3, respectively.
Values shown in (B) and (C) represent means ± SD
of 15 measurements from five independent
experiments; *p < 0.001, by Student’s t test.
(D) Expression levels of gp91phox, p67phox, and
p47phox determined by western blotting in undif-
ferentiated PLB-985 cells or those differentiated
with DMF or vitamin D3 into granulocytic or mono-
cytic cells, respectively. Note the lack of gp91phox,
but not p67phox or p47phox, in SIRPa-WT cells.
(E) Restoration of gp91phox expression after
reconstitution of gp91phox in SIRPa-WT and X-
CGD empty vector cells by retroviral transduc-
tion. The expression of gp91phox before (left panel)
and after (right panel) retroviral transduction was
evaluated by flow cytometry after incubation with
mAb 7D5 and goat-anti-mouse-IgG1 Alexa 633
antibody (solid histogram) or stained with isotype-
matched antibody (open histogram).
(F) PMA-induced NADPH-oxidase activity in
granulocytic SIRPa-WT and X-CGD empty vector
cells (white bars) in which gp91phox was recon-
stituted (black bars).
Data are presented as the mean ± SD of three
independent experiments each performed in
triplicate; *p < 0.001, by Student’s t test. See
also Figures S2 and S3.Inhibition of the NADPH Oxidase Involves Signaling via
the SIRPa Cytoplasmic ITIMs
The experiments described above suggested that direct
signaling through the cytoplasmic tail is involved in the regulation
of the NADPH oxidase and gp91phox protein expression. The
SIRPa cytoplasmic tail harbors ITIMs responsible for the recruit-
ment of the cytosolic tyrosine phosphatases SHP-1 and SHP-2
(Fujioka et al., 1996). Studies with dominant-negative SHP-1
in myeloid cells (Dong et al., 1999) and with phagocytes from
motheaten SHP-1-deficient mice (Kruger et al., 2000) demon-
strated that at least SHP-1 acts as a negative regulator of
the respiratory burst in myeloid cells. To investigate whether
SHP-1 and/or SHP-2 recruitment by SIRPa plays a critical role
in suppressing the respiratory burst by SIRPa, we mutated
each of the four tyrosines from the SIRPa ITIMs, or combinations
thereof, into phenylalanines and expressed the resultant proteins
in PLB-985 cells. To evaluate the binding of SHP-1 and SHP-2
to the SIRPa mutants, we performed immunoprecipitation
experiments. An analysis of the precipitates by western blottingCdemonstrated constitutive binding of SHP-1 and SHP-2 to
SIRPa, and this was eliminated or at least strongly reduced by
mutation of the ITIM tyrosines (Figure 3A). The same was
observed in the reverse experiment, i.e., SHP-1 or SHP-2
immunoprecipitation followed by western blotting with SIRPa
specific antibody (not shown). Mutation of all four ITIM tyrosines
(SIRPa-Y1, SIRPa-Y2, SIRPa-Y3, and SIRPa-Y4F) completely
restored the respiratory burst (Figure 3B) and gp91phox protein
expression (Figure 3C) to levels seen with the SIRPa-D87
cytoplasmic deletion mutant, suggesting that the ITIMs were
responsible for the inhibitory activity. The level of inhibition
obtained with the individual mutants correlated very well with
their capacity to recruit SHP-1 and SHP-2. For instance, the
membrane proximal Y1 appeared to be more important for the
negative regulation of the NADPH oxidase than its membrane
distal counterpart Y3.
To obtain insight into the level of gp91phox regulation by SIRPa,
we analyzed its mRNA levels by quantitative PCR (qPCR) in the
various PLB-985 mutants. Similarly to the gp91phox proteinell Reports 2, 748–755, October 25, 2012 ª2012 The Authors 751
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Figure 3. The Cytoplasmic ITIMs of SIRPa Are
Required for Inhibition of the NADPH Oxidase
(A) SHP-1 and SHP-2 binding to SIRPa-WT, SIRPa-D87,
and SIRPa tyrosine mutants was evaluated by immu-
noprecipitation of SIRPa, with mAb ED9 against rat
SIRPa, and western blotting with antibodies against
SHP-1, SHP-2, and SIRPa.
(B) PMA-induced NADPH oxidase activity in differentiated
granulocytic or monocytic PLB-985. Data are presented
as the mean ± SD of three independent experiments, each
performed in triplicate.
(C) Expression of surface gp91phox in differentiated
granulocytic or monocytic, or undifferentiated PLB-985
cells analyzed by flow cytometry using 7D5 mAb. Data
are presented as the mean ± SD of three independent
experiments.
(D) mRNA level of gp91phox in granulocytic or monocytic
differentiated, or undifferentiated cells detected by
RT-qPCR. Data are presented as the mean ± SD of two
independent experiments, each performed in duplicate.
(E) Intracellular killing of Salmonella bacteria. The different
cell lines were allowed to ingest S. enterica serovar
Typhimurium 14028s, and the numbers of intracellular
bacteria were determined 24 h after challenge. The levels
of Salmonella uptake at the start of the experiment were
comparable for all cells (not shown).
Data are presented as themean ±SDof three independent
experiments, each performed in triplicate; *p < 0.05, by
Student’s t test between the indicated conditions and the
empty vector control. See also Figure S3.
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Figure 4. CD47-SIRPa Interactions Are
Instrumental in Suppressing theRespiratory
Burst by SIRPa
(A) CD47 expression on PLB-985 cells as
demonstrated by flow cytometry with mAb B6H12.
(B) PMA-induced NADPH-oxidase activity in
granulocytic (black bars) or monocytic (gray bars)
PLB cells expressing each of the SIRPa extra-
cellular mutants (SIRPa-DECD, SIRPa-DV, or
SIRPa-V56M). Data are presented as the mean ±
SD of three independent experiments, each
performed in triplicate; *p < 0.05, by Student’s
t test between the indicated conditions and the
empty vector control.
(C) Binding of fluorescent beads coated with
human CD47-Fc protein to PLB-985 cells ex-
pressing rat-human chimeric SIRPa (WT) or empty
vector (EV) cells. Histograms show the total
CD47-bead binding (white area) and CD47-bead
binding after preincubation of the cells with
blocking mAb anti-rat SIRPa (ED9), anti-human
SIRPa (7C2), or both (ED9 + 7C2) (grey area).
(D) CD47-bead binding to the indicated mutants.
The bars show total binding in the absence of
antibodies, as well as the effects of preincubation
with anti-rat SIRPa mAb ED9 alone (ED9-block-
able), the calculated difference between pre-
incubation with bothmAbED9 plus the anti-human
mAb 7C2 and preincubation with ED9 (7C2-
blockable), and preincubation with both ED9 and
7C2 mAb (remaining).
See also Figure S4.expression, mRNA levels were low in the cells that express the
full-length SIRPa protein (Figure 3D), suggesting suppression
of transcriptional activity of the gp91phox/CYBB gene and/or
increased mRNA turnover. There was a strong correlation
among gp91phox mRNA, protein, and NADPH oxidase activity.
Finally, to investigate whether SIRPa expression and signal-
ing also affected the intracellular microbial killing, we evaluated
the various PLB-985 mutants for their capacity to kill intra-
cellular Salmonella bacteria. Enhanced Salmonella outgrowth
was observed in the PLB-985 X-CGD cells (Figure S3C),
directly indicating a role for the NADPH oxidase in Salmonella
killing. There was a good inverse relation between NADPH
oxidase activity and intracellular bacterial survival (Figure 3E).
For instance, the overexpression of SIRPa-WT tended to
enhance bacterial survival, whereas the SIRPa-D87 cyto-
plasmic deletion mutant resulted in lower bacterial survival
compared with that observed with the empty vector cells.
Also, the various Y mutants displayed a pattern of microbial
survival generally corresponding to their NADPH oxidase
capacity. The various mutants displayed similar levels of
Salmonella uptake (Figure S3D).
Collectively, these results show that SIRPa signaling via the
ITIMs negatively regulates the respiratory burst by controlling
the expression of gp91phox. It should be noted that we have
not yet been able to characterize the relevant downstream
signaling pathway(s). Of note, two transcription factor
complexes, ICSBP and HoxA10, were previously shown to
play a key role in the regulation of gp91phox gene expression,Cand both of these complexes are also subject to regulation
by SHP-1 and/or SHP-2 (Zhu et al., 2008; Lindsey et al., 2007;
Kautz et al., 2001). Both complexes are obvious candidates to
mediate the effects of SIRPa signaling on gp91phox gene ex-
pression, but our analysis of their activity by electrophoretic
mobility shift assay in the cell panel studied here did not provide
any evidence for their involvement (J.A.Z., unpublished data).
We are currently exploring alternative possibilities.
Inhibition of the NADPH Oxidase by SIRPa Involves
CD47-SIRPa Interactions
SIRPa has been shown to interact via its N-terminal Ig-like
domain with the broadly expressed CD47 molecule, and the
molecular basis for CD47-SIRPa interactions has been estab-
lished by mutagenesis and crystallography (Liu et al., 2007;
Hatherley et al., 2008). SIRPa ligation by CD47 triggers SIRPa
ITIM phosphorylation and SHP-1 and/or SHP-2 recruitment
and signaling, which in turn regulates downstream cellular
responses. As indicated above, the observation that SIRPa
mutants, such as the SIRPa-D87 and several of the ITIM tyrosine
mutants, display an enhanced oxidase activity and gp91phox
expression suggested a dominant-negative effect. We antici-
pated that the rat extracellular domain of the chimeric SIRPa
molecule that was introduced into the PLB-985 cells would
compete with the endogenous human SIRPa for CD47 binding,
thereby reducing inhibitory signaling through the latter. Indeed,
PLB-985 cells expressed CD47 on their surface (Figure 4A),
and CD47 expression levels were not significantly affected byell Reports 2, 748–755, October 25, 2012 ª2012 The Authors 753
expression of SIRPa or its mutants (Figure S4A). To directly
address whether CD47-SIRPa interactions contribute to the
inhibitory effect of SIRPa on the phagocyte respiratory burst,
we constructed several SIRPa variants in which the extracellular
ligand-binding domain was mutated. The mutants included
deletions of the entire extracellular region (SIRPa-DECD), the
N-terminal V-like Ig domain (SIRPa-DV), or a single point
mutation V56M within the N-terminal V-like Ig region that was
previously demonstrated to abolish CD47 binding (Liu et al.,
2007). The resulting cell lines were analyzed by FACS with anti-
bodies against rat and human SIRPa (Figure S4A) and western
blotting (Figure S4B), and were found to express comparable
surface levels of the various SIRPamolecules, with the expected
sizes. In all of the cells with SIRPa extracellular domain muta-
tions, the respiratory burst was strongly enhanced compared
with empty vector controls, yielding activities close to those
of the D87 mutant (Figure 4B). This suggested that similarly to
the mutants that affected SIRPa signaling, the mutants that
affected ligand binding were acting as dominant-negative
molecules, and in addition were sequestering relevant down-
stream signaling molecules such as SHP-1 and/or SHP-2.
It was clearly important to demonstrate a direct interaction
between the rat extracellular domains of our chimeric SIRPa
constructs and human CD47. For this purpose, we generated
a fusion protein of the extracellular domain of human CD47
and the Fc part of IgG1 (CD47-Fc), and developed a fluorescent
bead assay to measure cellular CD47 binding. Analysis of the
mutants demonstrated enhanced CD47 binding in SIRPa-WT
cells as compared with empty vector cells (Figure 4C). This
enhanced binding was prevented by blocking with the anti-rat
SIRPa-specific mAb ED9, directly demonstrating that the
chimeric rat-human SIRPa molecules are capable of binding
human CD47. In addition, this analysis also demonstrated
detectable CD47 binding by the endogenous human SIRPa
that could be inhibited by the mAb 7C2. Analysis of the other
mutants confirmed CD47 binding to SIRPa-WT, SIRPa-D87,
SIRPa-Y1, SIRPa-Y2, SIRPa-Y3, and SIRPa-Y4 cells, but not
to any of the SIRPa extracellular domain mutants (Figure 4D).
Collectively, these results indicate that CD47-SIRPa inter-
actions contribute to the inhibitory activity of SIRPa on the respi-
ratory burst. Clearly, we are formally unable to distinguish
whether cis (i.e., on the same cell) and/or trans (i.e., between
different cells) interactions are involved. However, considering
the relatively low culture density of our cells and the low
number of interactions between cells that occur during culture,
we think it is most likely that the observed effects occur primarily
as a result of cis interactions. However, it would seem that in the
context of a hematopoietic tissue such as the bone marrow
in vivo, where myeloid cells develop normally, the propensity
for trans interactions would be much higher, and such interac-
tions could also contribute to restricting gp91phox expression.
Taken together, these results demonstrate that CD47-SIRPa
interactions and ITIM-dependent downstream signaling via
SIRPa control the magnitude of the phagocyte respiratory burst
by regulating the expression levels of gp91phox. We propose that
CD47-SIRPa interactions participate in a homeostatic pathway
that acts on developing phagocytes and functions to control
excessive NADPH oxidase activity, and this serves to protect754 Cell Reports 2, 748–755, October 25, 2012 ª2012 The Authorshost cells and tissues against collateral oxidative damage during
infection and other inflammatory conditions. Among the next
challenges will be to provide insight into the mechanism(s) by
which SIRPa-signaling regulates gp91phox expression, and to
establish a contribution of CD47-SIRPa-dependent regulation
of the NADPH oxidase during inflammation and infection. The
latter issue may not be straightforward to address, because
other relevant processes, such as leukocyte transendothelial
migration, may also be regulated by CD47 and SIRPa (Liu
et al., 2002; de Vries et al., 2002).
EXPERIMENTAL PROCEDURES
Mice, Cells, and Culture
C57BL/6 mice with a targeted deletion of the SIRPa cytoplasmic region were
described previously (Yamao et al., 2002). PLB-985 and PLB-985 X-CGD cells
(Zhen et al., 1993), kindly provided by Dr. M. Dinauer (Indianapolis, IN, USA),
were grown in RPMI 1640 medium supplemented with 10% (v/v) fetal bovine
serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin
(complete medium) at 37C and 5% CO2. For granulocytic differentiation,
the cells were exposed to 0.65% (v/v) DMF (Sigma-Aldrich, St. Louis, MO,
USA) for 5–6 days. Monocytic differentiation was achieved by culturing in
the presence of 100 nM VitD3 (1a, 25-dihydroxyvitamin D3; Sigma-Aldrich)
for 5–6 days.
Measurement of Respiratory Burst Activity
Activity of the respiratory burst after PMA (Sigma-Aldrich) or STZ (ICN
Biochemicals, Cleveland, OH, USA) stimulation in transduced PLB-985 or
PLB-985 X-CGD cells was measured with the Amplex Red (10-acetyl-3,7-
dihydroxyphenoxazine) Hydrogen Peroxide Assay kit (Molecular Probes,
Eugene, OR, USA) as previously described (Kuijpers et al., 2007). For informa-
tion about antibodies, mice, isolation and culture of other cells, retroviral
transductions, flow-cytometric analysis, qPCR, immunoprecipitation, western
blotting, and intracellular killing of Salmonella, see Extended Experimental
Procedures.
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